FORT MILL, SC / ACCESSWIRE / May 6, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) a MedTech company pioneering products in the growing field of cardiac electrophysiology, including its VIVO™ ...
LONG BEACH, Calif. -- Big Data may provide some answers to the many questions surrounding advanced catheter-based pulmonary ...
Scientia Vascular announced FDA clearance of the Plato 17 microcatheter and Socrates 38 aspiration catheter. According to ...
A new study suggests that the non-surgical insertion of abdominal catheters for peritoneal dialysis is safe and ...
--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new ...
Catheter Precision, Inc. (NYSE American:VTAK), is pleased to announce and welcome Marie-Claude Jacques as Chief Commercial ...
New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV) demonstrated that ...
New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute ...
The Medtronic Sphere-360 pulsed field ablation catheter uses nitinol for a feature that's unique within Medtronic's PFA ...
Catheter Precision, Inc. (NYSE American:VTAK) ($VTAK), a leading MedTech company specializing in innovative products for ...
CMS has proposed discontinuing two existing HCPCS codes for intermittent urinary catheters, A4351 and A4352, and establishing five new codes in response to a request from AAHomecare and ...
Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV) using the new Precision 2 Delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback